Literature DB >> 33467606

Functional Heterogeneity and Therapeutic Targeting of Tissue-Resident Memory T Cells.

Esmé T I van der Gracht1, Felix M Behr1, Ramon Arens1.   

Abstract

Tissue-resident memory T (TRM) cells mediate potent local innate and adaptive immune responses and provide long-lasting protective immunity. TRM cells localize to many different tissues, including barrier tissues, and play a crucial role in protection against infectious and malignant disease. The formation and maintenance of TRM cells are influenced by numerous factors, including inflammation, antigen triggering, and tissue-specific cues. Emerging evidence suggests that these signals also contribute to heterogeneity within the TRM cell compartment. Here, we review the phenotypic and functional heterogeneity of CD8+ TRM cells at different tissue sites and the molecular determinants defining CD8+ TRM cell subsets. We further discuss the possibilities of targeting the unique cell surface molecules, cytokine and chemokine receptors, transcription factors, and metabolic features of TRM cells for therapeutic purposes. Their crucial role in immune protection and their location at the frontlines of the immune defense make TRM cells attractive therapeutic targets. A better understanding of the possibilities to selectively modulate TRM cell populations may thus improve vaccination and immunotherapeutic strategies employing these potent immune cells.

Entities:  

Keywords:  T cells; heterogeneity; immunotherapy; therapeutic targeting; tissue residency

Year:  2021        PMID: 33467606      PMCID: PMC7829818          DOI: 10.3390/cells10010164

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  138 in total

Review 1.  Chemokines, chemokine receptors and small-molecule antagonists: recent developments.

Authors:  James J Onuffer; Richard Horuk
Journal:  Trends Pharmacol Sci       Date:  2002-10       Impact factor: 14.819

2.  Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus.

Authors:  Thomas Gebhardt; Linda M Wakim; Liv Eidsmo; Patrick C Reading; William R Heath; Francis R Carbone
Journal:  Nat Immunol       Date:  2009-03-22       Impact factor: 25.606

3.  KLRG1+ Effector CD8+ T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity.

Authors:  Dietmar Herndler-Brandstetter; Harumichi Ishigame; Ryo Shinnakasu; Valerie Plajer; Carmen Stecher; Jun Zhao; Melanie Lietzenmayer; Lina Kroehling; Akiko Takumi; Kohei Kometani; Takeshi Inoue; Yuval Kluger; Susan M Kaech; Tomohiro Kurosaki; Takaharu Okada; Richard A Flavell
Journal:  Immunity       Date:  2018-04-03       Impact factor: 31.745

4.  Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer.

Authors:  Anusha-Preethi Ganesan; James Clarke; Oliver Wood; Eva M Garrido-Martin; Serena J Chee; Toby Mellows; Daniela Samaniego-Castruita; Divya Singh; Grégory Seumois; Aiman Alzetani; Edwin Woo; Peter S Friedmann; Emma V King; Gareth J Thomas; Tilman Sanchez-Elsner; Pandurangan Vijayanand; Christian H Ottensmeier
Journal:  Nat Immunol       Date:  2017-06-19       Impact factor: 25.606

5.  Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism.

Authors:  Youdong Pan; Tian Tian; Chang Ook Park; Serena Y Lofftus; Shenglin Mei; Xing Liu; Chi Luo; John T O'Malley; Ahmed Gehad; Jessica E Teague; Sherrie J Divito; Robert Fuhlbrigge; Pere Puigserver; James G Krueger; Gökhan S Hotamisligil; Rachael A Clark; Thomas S Kupper
Journal:  Nature       Date:  2017-02-20       Impact factor: 49.962

6.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

7.  Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8+ TRM Cells and Reduces Ocular Herpes Simplex Infection and Disease in HLA Transgenic Rabbits.

Authors:  Soumyabrata Roy; Pierre-Gregoire Coulon; Swayam Prakash; Ruchi Srivastava; Roger Geertsema; Nisha Dhanushkodi; Cynthia Lam; Vivianna Nguyen; Elyssa Gorospe; Angela M Nguyen; Stephanie Salazar; Nuha I Alomari; Wasay R Warsi; Lbachir BenMohamed
Journal:  J Virol       Date:  2019-08-28       Impact factor: 6.549

8.  Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients.

Authors:  Timothy Murray; Silvia A Fuertes Marraco; Petra Baumgaertner; Natacha Bordry; Laurène Cagnon; Alena Donda; Pedro Romero; Grégory Verdeil; Daniel E Speiser
Journal:  Front Immunol       Date:  2016-12-12       Impact factor: 7.561

9.  Antigen-dependent competition shapes the local repertoire of tissue-resident memory CD8+ T cells.

Authors:  Andreas Muschaweckh; Veit R Buchholz; Anne Fellenzer; Christian Hessel; Paul-Albert König; Sha Tao; Ronny Tao; Mathias Heikenwälder; Dirk H Busch; Thomas Korn; Wolfgang Kastenmüller; Ingo Drexler; Georg Gasteiger
Journal:  J Exp Med       Date:  2016-11-29       Impact factor: 14.307

10.  Targeted Expansion of Tissue-Resident CD8+ T Cells to Boost Cellular Immunity in the Skin.

Authors:  Samuel J Hobbs; Jeffrey C Nolz
Journal:  Cell Rep       Date:  2019-12-03       Impact factor: 9.423

View more
  2 in total

1.  Distinct Effector Programs of Brain-Homing CD8+ T Cells in Multiple Sclerosis.

Authors:  Steven C Koetzier; Jamie van Langelaar; Marie-José Melief; Annet F Wierenga-Wolf; Cato E A Corsten; Katelijn M Blok; Cindy Hoeks; Bieke Broux; Beatrijs Wokke; Marvin M van Luijn; Joost Smolders
Journal:  Cells       Date:  2022-05-13       Impact factor: 7.666

Review 2.  The Emerging Interplay Between Recirculating and Tissue-Resident Memory T Cells in Cancer Immunity: Lessons Learned From PD-1/PD-L1 Blockade Therapy and Remaining Gaps.

Authors:  Silvia Gitto; Ambra Natalini; Fabrizio Antonangeli; Francesca Di Rosa
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.